CTRI/2011/11/002112已完成未知
Evaluation of dermatological safety and adverse reaction of Tactivin Immunoplus (Immunomodulator) cream, Tactivin Anti Wrinkle cream and Tomicid (Antibacterial peptide) cream along with their Placebo with a 48 hours closed patch skin sensitization test on 24 healthy adult volunteers
Remedia Therapeutics Pvt Ltd0 个研究点目标入组 24 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 24
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Healthy male and female adult volunteers
- •Subjects willing to give a written informed consent.
- •Subjects age group 18 - 55 years
- •Subjects willing to maintain the patch test in position for 48 hours
- •Subject has not participated in a similar investigation in the past two weeks.
- •Subjects willing to come for regular follow up.
- •Subjects ready to follow instructions during the study period.
排除标准
- •The investigator can decide to withdraw a subject from the trial at any moment because
- •One of the criteria of non inclusion occurred during the period of observation.
- •Indication of intolerance to the studied product requiring that the investigation should
- •be stopped.
研究者
相似试验
招募中
不适用
Safety testing of cosmetic product using Patch TestCTRI/2021/07/035262Entice Supplements Pvt Ltd
已完成
1 期
Safety of the test products to be checked.CTRI/2023/09/057621ITC Life Sciences Technology Centre24
已完成
不适用
Evaluation of the safety of the product by skin sensitivity test on healthy human volunteers.CTRI/2016/12/007573ITC Life Sciences and Technology Centre24
已完成
不适用
Dermatology study in healthy volunteersCTRI/2017/02/007875ITC Life Sciences and Technology Centre24
已完成
不适用
To understand the skin sensitivity of investigational products by assessing the irritation after patch application on healthy human volunteersCTRI/2012/12/003206Kao Corporation24